BACKGROUND:Chemoradiotherapy (CRT) is becoming more widely used for head and neck cancer. However, there are conflicting theories regarding the best management options for patients with advanced nodal disease. METHODS: From 1990 to 1999, we treated 96 patients with N1-N2 neck disease by concomitant CRT for organ preservation, using weeklycarboplatin or a low daily dose of cisplatin, followed by a "watch-and-see" policy for the neck. In the present study, we retrospectively analyzed the treatment outcome in 63 of these patients who received definitive CRT for primary and neck diseases and were monitored for neck disease for more than 2 years. RESULTS: In 12 of the 22 (55%) N1 patients, CRT successfully controlled the neck disease. CRT was successful in 18 of the 41 (44%) patients with N2 disease. In 6 (60%) of 10 patients with residual or recurrent N1 disease, salvage surgery was successful. Of the 23 patients with residual or recurrent N2 disease, salvage surgery was successful in 8 patients (35%). The group of patients who showed a clinical complete response (CCR) to CRT had an overall survival rate of 62.4% (33 patients), whereas for those with a less than complete response (<CCR), the figure was 13.3% (30 patients; P < 0.001). Among the <CCR-neck group, patients who underwent neck dissection (ND) as well (n = 20) did not have a significantly better overall survival than those who did not undergo ND (n = 10; P = 0.069). CONCLUSION: We propose a treatment plan for neck disease that involves observing the neck closely following CRT. ND should be planned only when there is evidence that neck disease exists.
RCT Entities:
BACKGROUND: Chemoradiotherapy (CRT) is becoming more widely used for head and neck cancer. However, there are conflicting theories regarding the best management options for patients with advanced nodal disease. METHODS: From 1990 to 1999, we treated 96 patients with N1-N2 neck disease by concomitant CRT for organ preservation, using weekly carboplatin or a low daily dose of cisplatin, followed by a "watch-and-see" policy for the neck. In the present study, we retrospectively analyzed the treatment outcome in 63 of these patients who received definitive CRT for primary and neck diseases and were monitored for neck disease for more than 2 years. RESULTS: In 12 of the 22 (55%) N1 patients, CRT successfully controlled the neck disease. CRT was successful in 18 of the 41 (44%) patients with N2 disease. In 6 (60%) of 10 patients with residual or recurrent N1 disease, salvage surgery was successful. Of the 23 patients with residual or recurrent N2 disease, salvage surgery was successful in 8 patients (35%). The group of patients who showed a clinical complete response (CCR) to CRT had an overall survival rate of 62.4% (33 patients), whereas for those with a less than complete response (<CCR), the figure was 13.3% (30 patients; P < 0.001). Among the <CCR-neck group, patients who underwent neck dissection (ND) as well (n = 20) did not have a significantly better overall survival than those who did not undergo ND (n = 10; P = 0.069). CONCLUSION: We propose a treatment plan for neck disease that involves observing the neck closely following CRT. ND should be planned only when there is evidence that neck disease exists.
Authors: P Lavertu; D J Adelstein; J P Saxton; M Secic; J R Wanamaker; I Eliachar; B G Wood; M Strome Journal: Head Neck Date: 1997-10 Impact factor: 3.147
Authors: R A Weisman; R D Christen; V E Jones; C W Kerber; S L Seagren; L A Orloff; S L Glassmeyer; S B Howell; K T Robbins Journal: Laryngoscope Date: 1998-06 Impact factor: 3.325
Authors: Scott A McHam; David J Adelstein; Lisa A Rybicki; Pierre Lavertu; Ramon M Esclamado; Benjamin G Wood; Marshall Strome; Marjorie A Carroll Journal: Head Neck Date: 2003-10 Impact factor: 3.147
Authors: B M Dubray; J P Bataini; J Bernier; H D Thames; C Lave; B Asselain; C Jaulerry; F Brunin; D Pontvert Journal: Int J Radiat Oncol Biol Phys Date: 1993-01 Impact factor: 7.038
Authors: Athanassios Argiris; Kerstin M Stenson; Bruce E Brockstein; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Prathima Jayaram; Louis Portugal; Barry L Wenig; Fred R Rosen; Daniel J Haraf; Everett E Vokes Journal: Head Neck Date: 2004-05 Impact factor: 3.147
Authors: A Relic; M Scheich; J Stapf; C Voelter; F Hoppe; R Hagen; L Pfreundner Journal: Eur Arch Otorhinolaryngol Date: 2009-03-14 Impact factor: 2.503